Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.

Yoo, E K

Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. [electronic resource] - Journal of the American Academy of Dermatology Aug 2001 - 208-16 p. digital

Publication Type: Case Reports; Journal Article

0190-9622

10.1067/mjd.2001.116345 doi


Aged
Antineoplastic Agents--therapeutic use
Cytotoxicity, Immunologic
Gene Rearrangement, T-Lymphocyte
Genes, T-Cell Receptor beta--genetics
Genes, T-Cell Receptor gamma--genetics
Humans
Immunologic Factors--therapeutic use
Interferon alpha-2
Interferon-alpha--therapeutic use
Interferon-gamma--biosynthesis
Interleukin-4--biosynthesis
Killer Cells, Natural--immunology
Male
Middle Aged
Photopheresis
Polymerase Chain Reaction
Recombinant Proteins
Sezary Syndrome--drug therapy
Skin Neoplasms--drug therapy
T-Lymphocyte Subsets
Th1 Cells--immunology